Ni Q, Pan C, Guo Q, Wang P, Yang Y, Zhang W, Dai S. A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma.
Dose Response 2022;
20:15593258221103373. [PMID:
35615569 PMCID:
PMC9125098 DOI:
10.1177/15593258221103373]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2022] [Accepted: 05/09/2022] [Indexed: 12/03/2022] Open
Abstract
Lung squamous cell cancer (SCC) and accounts for approximately 20%-30% of all lung cancers. Surgery, chemotherapy and radiotherapy are the main treatments for lung SCC patients. A case with lung SCC patient who was treated using iodine 125 seeds (I-125) because the location of the tumor was adjacent to the great vessels. I-125 is an ideal brachytherapy for lung SCC patients with large masses who lost the chance of operation. I-125 is an adjuvant therapy, combined with chemotherapy and molecular targeting therapy might serve to improve the prognosis of lung SCC patients.
Collapse